Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: TICAGRELOR, . Treffer: 18
2023
Sandner, S; Kastrati, A; Niessner, A; Boning, A; Zeymer, U; Conradi, L; Danner, B; Zimpfer, D; Farber, G; Manville, E; Schunkert, H; von Scheidt, M
Sex differences among patients receiving ticagrelor monotherapy or aspirin after coronary bypass surgery: A prespecified subgroup analysis of the TiCAB trial
INT J CARDIOL. 2023; 370: 129-135.
Doi: 10.1016/j.ijcard.2022.10.166
Web of Science
PubMed
FullText
FullText_MUG
2022
Sandner, SE; Schunkert, H; Kastrati, A; Milojevic, M; Böning, A; Zimpfer, D; Zellmer, S; Wiedemann, D; Laufer, G; von, Scheidt, M, , TiCAB, Investigators
Ticagrelor or Aspirin After Coronary Artery Bypass in Patients With Chronic Kidney Disease.
Ann Thorac Surg. 2022; 113(2): 554-562.
Doi: 10.1016/j.athoracsur.2021.03.061
Web of Science
PubMed
FullText
FullText_MUG
Schoerghuber, M; Pregartner, G; Berghold, A; Lindenau, I; Zweiker, R; Voetsch, A; Mahla, E; Zirlik, A
How do type of preoperative P2Y12 receptor inhibitor and withdrawal time affect bleeding? Protocol of a systematic review and individual patient data meta-analysis.
BMJ Open. 2022; 12(3): e060404
Doi: 10.1136/bmjopen-2021-060404
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Voetsch, A; Pregartner, G; Berghold, A; Seitelberger, R; Schoerghuber, M; Toller, W; Mahla, E
How Do Type of Preoperative P2Y12 Receptor Inhibitor and Withdrawal Time Affect Bleeding?
Ann Thorac Surg. 2021; 111(1):77-84
Doi: 10.1016/j.athoracsur.2020.04.126
Web of Science
PubMed
FullText
FullText_MUG
2020
Bärnthaler, T; Mahla, E; Toth, GG; Schuligoi, R; Prüller, F; Buschmann, E; Heinemann, A
Supplemental Fibrinogen Restores Platelet Inhibitor-Induced Reduction in Thrombus Formation without Altering Platelet Function: An In Vitro Study.
Thromb Haemost. 2020; 120(11):1548-1556
Doi: 10.1055/s-0040-1715445
Web of Science
PubMed
FullText
FullText_MUG
Gager, GM; Jilma, B; Winter, MP; Hengstenberg, C; Lang, IM; Toma, A; Prüller, F; Wallner, M; Kolesnik, E; von Lewinski, D; Siller-Matula, JM
Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patients.
Eur J Clin Invest. 2020; 50(11):e13304-e13304
Doi: 10.1111/eci.13304
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Schittek, GA; Simonis, H; Fischer, M; Soukup, J
[Severe Shock Symptoms Due to Ticagrelor Related Anaphylactoid Reaction Following ST Elevation Myocardial Infarction].
Anasthesiol Intensivmed Notfallmed Schmerzther. 2019; 54(10): 630-634.
Doi: 10.1055/a-0901-6613
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Takahashi, K; Serruys, PW; Chichareon, P; Chang, CC; Tomaniak, M; Modolo, R; Kogame, N; Magro, M; Chowdhary, S; Eitel, I; Zweiker, R; Ong, P; Ottesen, MM; Tijssen, JGP; Wykrzykowska, JJ; de Winter, RJ; Garg, S; Stoll, HP; Hamm, C; Steg, PG; Onuma, Y; Valgimigli, M; Vranckx, P; Carrie, D; Windecker, S
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI
J AM COLL CARDIOL. 2019; 74(16): 2015-2027.
Doi: 10.1016/j.jacc.2019.08.997
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tomaniak, M; Chichareon, P; Onuma, Y; Deliargyris, EN; Takahashi, K; Kogame, N; Modolo, R; Chang, CC; Rademaker-Havinga, T; Storey, RF; Dangas, GD; Bhatt, DL; Angiolillo, DJ; Hamm, C; Valgimigli, M; Windecker, S; Steg, PG; Vranckx, P; Serruys, PW; GLOBAL LEADERS Trial Investigators
Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.
JAMA Cardiol. 2019; 4(11):1092-1101
Doi: 10.1001/jamacardio.2019.3355
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Winter, MP; Schneeweiss, T; Cremer, R; Biesinger, B; Hengstenberg, C; Prüller, F; Wallner, M; Kolesnik, E; von Lewinski, D; Lang, IM; Siller-Matula, JM
Platelet reactivity patterns in patients treated with dual antiplatelet therapy.
Eur J Clin Invest. 2019; 9(1):e13102-e13102
Doi: 10.1111/eci.13102
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Winter, MP; von Lewinski, D; Wallner, M; Prüller, F; Kolesnik, E; Hengstenberg, C; Siller-Matula, JM
Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study.
Sci Rep. 2019; 9(1):8194-8194
Doi: 10.1038/s41598-019-44673-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Siller-Matula, JM; Petre, A; Delle-Karth, G; Huber, K; Ay, C; Lordkipanidzé, M; De Caterina, R; Kolh, P; Mahla, E; Gersh, BJ
Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis.
Eur Heart J Acute Cardiovasc Care. 2017; 6(8):753-770
Doi: 10.1177/2048872615585516
Web of Science
PubMed
FullText
FullText_MUG
Tscharre, M; Egger, F; Machata, M; Rohla, M; Michael, N; Neumayr, M; Zweiker, R; Hajos, J; Adlbrecht, C; Suppan, M; Helmreich, W; Eber, B; Huber, K; Weiss, TW
Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry.
PLoS One. 2017; 12(6):e0179349-e0179349
Doi: 10.1371/journal.pone.0179349
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Stachon, P; Ahrens, I; Bode, C; Zirlik, A
Dual pathway therapy in acute coronary syndrome.
J THROMB THROMBOLYS. 2016; 42(2): 254-260.
Doi: 10.1007/s11239-015-1306-3
Web of Science
PubMed
FullText
FullText_MUG
Weiss, TW; Aichinger, J; Huber, K; Speidl, WS; Watzinger, N; Zweiker, R; Alber, HF
Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction.
Wien Klin Wochenschr. 2016; 128(11-12):450-457
Doi: 10.1007/s00508-016-1016-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Ahrens, I; Bode, C; Zirlik, A
Anticoagulation during and after acute coronary syndrome.
HAMOSTASEOLOGIE. 2014; 34(1): 72-77.
Doi: 10.5482/HAMO-13-09-0048
Web of Science
PubMed
FullText
FullText_MUG
Mahla, E; Raggam, R; Toller, W
Platelet function testing to time surgery in patients on dual antiplatelet therapy?
Hamostaseologie. 2014; 34(1):40-45
Doi: 10.5482/HAMO-13-06-0032
Web of Science
PubMed
FullText
FullText_MUG
2012
Mahla, E; Höchtl, T; Prüller, F; Freynhofer, MK; Huber, K
Platelet function: new drugs, new assays : Possible impacts on operative medicine?
Anaesthesist. 2012; 61(6):483-496
Doi: 10.1007/s00101-012-2041-1
Web of Science
PubMed
FullText
FullText_MUG